Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oncology
1.2.3 Ocular Disorders
1.2.4 Respiratory Disorders
1.2.5 Liver Diseases
1.2.6 Other
1.3 Market by Application
1.3.1 Global RNAi Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research
1.3.3 Therapeutics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNAi Technologies Market Perspective (2019-2030)
2.2 RNAi Technologies Growth Trends by Region
2.2.1 Global RNAi Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNAi Technologies Historic Market Size by Region (2019-2024)
2.2.3 RNAi Technologies Forecasted Market Size by Region (2025-2030)
2.3 RNAi Technologies Market Dynamics
2.3.1 RNAi Technologies Industry Trends
2.3.2 RNAi Technologies Market Drivers
2.3.3 RNAi Technologies Market Challenges
2.3.4 RNAi Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi Technologies Players by Revenue
3.1.1 Global Top RNAi Technologies Players by Revenue (2019-2024)
3.1.2 Global RNAi Technologies Revenue Market Share by Players (2019-2024)
3.2 Global RNAi Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNAi Technologies Revenue
3.4 Global RNAi Technologies Market Concentration Ratio
3.4.1 Global RNAi Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi Technologies Revenue in 2023
3.5 RNAi Technologies Key Players Head office and Area Served
3.6 Key Players RNAi Technologies Product Solution and Service
3.7 Date of Enter into RNAi Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi Technologies Breakdown Data by Type
4.1 Global RNAi Technologies Historic Market Size by Type (2019-2024)
4.2 Global RNAi Technologies Forecasted Market Size by Type (2025-2030)
5 RNAi Technologies Breakdown Data by Application
5.1 Global RNAi Technologies Historic Market Size by Application (2019-2024)
5.2 Global RNAi Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNAi Technologies Market Size (2019-2030)
6.2 North America RNAi Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNAi Technologies Market Size by Country (2019-2024)
6.4 North America RNAi Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNAi Technologies Market Size (2019-2030)
7.2 Europe RNAi Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNAi Technologies Market Size by Country (2019-2024)
7.4 Europe RNAi Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNAi Technologies Market Size (2019-2030)
8.2 Asia-Pacific RNAi Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNAi Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific RNAi Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNAi Technologies Market Size (2019-2030)
9.2 Latin America RNAi Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNAi Technologies Market Size by Country (2019-2024)
9.4 Latin America RNAi Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi Technologies Market Size (2019-2030)
10.2 Middle East & Africa RNAi Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNAi Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa RNAi Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Detail
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi Technologies Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNAi Technologies Business (2019-2024)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Benitec Biopharma Ltd
11.2.1 Benitec Biopharma Ltd Company Detail
11.2.2 Benitec Biopharma Ltd Business Overview
11.2.3 Benitec Biopharma Ltd RNAi Technologies Introduction
11.2.4 Benitec Biopharma Ltd Revenue in RNAi Technologies Business (2019-2024)
11.2.5 Benitec Biopharma Ltd Recent Development
11.3 Filmtec Corporation
11.3.1 Filmtec Corporation Company Detail
11.3.2 Filmtec Corporation Business Overview
11.3.3 Filmtec Corporation RNAi Technologies Introduction
11.3.4 Filmtec Corporation Revenue in RNAi Technologies Business (2019-2024)
11.3.5 Filmtec Corporation Recent Development
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Detail
11.4.2 Ionis Pharmaceuticals Business Overview
11.4.3 Ionis Pharmaceuticals RNAi Technologies Introduction
11.4.4 Ionis Pharmaceuticals Revenue in RNAi Technologies Business (2019-2024)
11.4.5 Ionis Pharmaceuticals Recent Development
11.5 Quark Pharmaceuticals Inc.
11.5.1 Quark Pharmaceuticals Inc. Company Detail
11.5.2 Quark Pharmaceuticals Inc. Business Overview
11.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Introduction
11.5.4 Quark Pharmaceuticals Inc. Revenue in RNAi Technologies Business (2019-2024)
11.5.5 Quark Pharmaceuticals Inc. Recent Development
11.6 RXI Pharmaceuticals
11.6.1 RXI Pharmaceuticals Company Detail
11.6.2 RXI Pharmaceuticals Business Overview
11.6.3 RXI Pharmaceuticals RNAi Technologies Introduction
11.6.4 RXI Pharmaceuticals Revenue in RNAi Technologies Business (2019-2024)
11.6.5 RXI Pharmaceuticals Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen RNAi Technologies Introduction
11.7.4 Qiagen Revenue in RNAi Technologies Business (2019-2024)
11.7.5 Qiagen Recent Development
11.8 Invitrogen
11.8.1 Invitrogen Company Detail
11.8.2 Invitrogen Business Overview
11.8.3 Invitrogen RNAi Technologies Introduction
11.8.4 Invitrogen Revenue in RNAi Technologies Business (2019-2024)
11.8.5 Invitrogen Recent Development
11.9 Ambion
11.9.1 Ambion Company Detail
11.9.2 Ambion Business Overview
11.9.3 Ambion RNAi Technologies Introduction
11.9.4 Ambion Revenue in RNAi Technologies Business (2019-2024)
11.9.5 Ambion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details